1. Home
  2. NKTX vs ARL Comparison

NKTX vs ARL Comparison

Compare NKTX & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.60

Market Cap

198.2M

Sector

Health Care

ML Signal

HOLD

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

N/A

Current Price

$14.85

Market Cap

233.9M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
NKTX
ARL
Founded
2015
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
233.9M
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
NKTX
ARL
Price
$2.60
$14.85
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$11.33
N/A
AVG Volume (30 Days)
488.9K
8.2K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
11.88
206.59
EPS
N/A
N/A
Revenue
N/A
$50,014,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.70
52 Week Low
$1.63
$12.42
52 Week High
$3.65
$20.00

Technical Indicators

Market Signals
Indicator
NKTX
ARL
Relative Strength Index (RSI) 44.03 51.77
Support Level $2.59 $13.25
Resistance Level $2.78 $16.76
Average True Range (ATR) 0.22 0.52
MACD -0.02 0.00
Stochastic Oscillator 28.57 66.51

Price Performance

Historical Comparison
NKTX
ARL

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: